Panacea Biotec Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks
- May 7, 2026
- Posted by: Kashish Aggarwal
- Category: News
The Panacea Biotec share price target for 2026 stands at Rs 578 as per the latest analyst forecast, implying 29 percent upside from the current market price of Rs 448. Investors tracking the Panacea Biotec share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Panacea Biotec share price target thesis updated April 2026.
Click Here to Get Free Investment Predictions on Univest
Track live Panacea Biotec price, FII or DII flows and analyst targets on the Univest Screener.
Panacea Biotec Company Overview
Tap to Access Best Research on Univest
Panacea Biotec (NSE: PANACEABIO) is a listed company in India’s Pharma sector with a market capitalisation of Rs 1232 crore. At CMP Rs 448 against a 52 week range of Rs 358 to Rs 530, the stock currently offers meaningful upside to the analyst price forecast of Rs 578. For more share price target analysis, visit Univest Blogs.
| Parameter | Value |
|---|---|
| NSE Ticker | PANACEABIO |
| Sector | Pharma |
| CMP April 2026 | Rs 448 |
| 52 Week High | Rs 530 |
| 52 Week Low | Rs 358 |
| Market Cap | Rs 1232 crore |
| Trailing P/E | 28x |
| 12M Analyst Price Forecast | Rs 578 |
| Bull Case Target | Rs 694 |
| Bear Case Target | Rs 340 |
Why Analysts Set the Panacea Biotec Share Price Target at Rs 578 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the key year where analysts expect Panacea Biotec to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 448 and the Panacea Biotec share price target 2026 of Rs 578. Analysts project 15 to 20 percent PAT growth in FY27. Track Q4 results live on the Univest Screener.
Export market penetration driving growth
Export market penetration driving growth is a key growth driver that analysts highlight in supporting the Panacea Biotec share price target of Rs 578. The Pharma sector is expanding at 12 to 18 percent annually, and Panacea Biotec is well-positioned to capture a rising share. Discover top Pharma stocks on the Univest Screener.
Import substitution benefiting domestic players
Import substitution benefiting domestic players provides an additional lever that can help Panacea Biotec exceed analyst projections and potentially push the stock toward the bull case target of Rs 694. Compare Panacea Biotec with sector peers on the Univest Screener.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s rate cut cycle that commenced in 2026 reduces Panacea Biotec’s borrowing costs and stimulates end-market demand, supporting the Panacea Biotec share price target 2026 of Rs 578.
Union Budget 2026-27 Policy Support
Budget 2026-27 capex continuity and PLI scheme extensions create a constructive backdrop for Panacea Biotec’s Pharma business, directly supporting the Panacea Biotec share price target 2026 bull case of Rs 694.
Bull Case, Base Case and Bear Case for Panacea Biotec Share Price Target
| Scenario | Target | Key Assumption |
|---|---|---|
| Bull Case | Rs 694 | FY27 revenue growth exceeds 25 percent, margin expansion of 200 bps, sector re-rating |
| Base Case Forecast | Rs 578 | FY27 revenue growth of 15 to 18 percent, stable margins, current P/E sustained |
| Bear Case | Rs 340 | Revenue growth disappoints below 10 percent, margin pressure, valuation de-rating |
For live tracking of Panacea Biotec analyst price targets and ratings, use the Univest Screener.
Key Risks to the Panacea Biotec Share Price Target
Earnings Miss Risk
If Panacea Biotec reports quarterly earnings below expectations, the Panacea Biotec share price target will likely face downward revision. Watch Q4 FY26 results closely on Univest Screener.
Macro and Global Headwinds
The US 26 percent reciprocal tariff announcement of April 2026 has created global macro uncertainty that adds near-term risk to the Panacea Biotec share price target 2026 timeline.
Sector-Specific Risks
Regulatory changes, input cost volatility, and competitive intensity in the Pharma space could pressure margins and delay realisation of the Panacea Biotec share price target of Rs 578.
FII Outflows
Continued FII selling in Indian equities could suppress the valuation multiples needed for Panacea Biotec to reach its analyst price forecast of Rs 578 within the 12 month horizon.
Panacea Biotec Financial Snapshot FY25 to FY27
| Metric | FY25 Actual | FY26 Estimate | FY27 Estimate |
|---|---|---|---|
| Revenue (Rs Cr) | Refer NSE filing | Refer NSE filing | Refer NSE/BSE filing |
| EBITDA Margin | Refer NSE filing | Refer NSE filing | Expected expansion |
| PAT (Rs Cr) | Refer NSE filing | Refer NSE filing | 15 to 20 percent growth |
| Market Cap | Rs 1232 crore | Higher at 52W peak | Tracks price movement |
| P/E Ratio | 28x | Current level | Target implies re-rating |
| 52 Week High / Low | Rs 530 / Rs 358 | ||
If you want to track Panacea Biotec financial metrics, analyst ratings and peer comparisons in real time, check the Univest Screener for live data.
Technical Outlook for Panacea Biotec Share Price
Panacea Biotec is trading at Rs 448, currently attempting to build a base above its 52 week low of Rs 358. The stock needs to reclaim its 200 day moving average to confirm a meaningful recovery trend. The Panacea Biotec share price target of Rs 578 set by analysts assumes fundamental delivery over the next 12 months rather than near-term price action. Download the Univest iOS App or Univest Android App to track Panacea Biotec live price and set alerts.
Conclusion
The Panacea Biotec share price target 2026 of Rs 578 reflects analyst conviction on FY27 earnings delivery, structural sector tailwinds, and the favourable domestic macro environment. The bull case of Rs 694 is achievable if the company executes above expectations. Investors should monitor quarterly earnings, FII ownership trends and management commentary closely. For real-time tracking and research, use the Univest Screener.
This article is for informational and educational purposes only and is not investment advice. Univest is SEBI registered (INH000013776). Please consult a SEBI registered financial advisor before making any investment decision.
Frequently Asked Questions
What is the Panacea Biotec share price target for 2026?
The Panacea Biotec share price target for 2026 is Rs 578 as per the analyst price forecast, implying 29 percent upside from the current price of Rs 448. The bull case target is Rs 694 and the bear case is Rs 340.
Is Panacea Biotec a good buy at Rs 448?
At Rs 448, Panacea Biotec trades at a trailing P/E of 28x and offers potential upside to the analyst price forecast of Rs 578. Whether it is a good buy depends on your investment horizon and risk appetite. Always consult a SEBI registered financial advisor.
What is the 52 week high and low of Panacea Biotec?
The 52 week high of Panacea Biotec is Rs 530 and the 52 week low is Rs 358. The current CMP of Rs 448 positions the stock at a meaningful discount to its peak, which is factored into the analyst Panacea Biotec share price target 2026.
What sector does Panacea Biotec belong to?
Panacea Biotec belongs to India’s Pharma sector and trades on NSE with the ticker PANACEABIO. Track the entire Pharma sector on the Univest Screener.
What is the bull case for Panacea Biotec share price?
The bull case for Panacea Biotec share price is Rs 694, which assumes revenue growth exceeding 25 percent in FY27, margin expansion of 200 basis points, and a positive re-rating of the Pharma sector. This scenario requires strong execution and supportive macro conditions.
What are the key risks to the Panacea Biotec share price target?
Key risks include earnings miss in upcoming quarters, continued FII selling, regulatory headwinds in the Pharma sector, raw material cost volatility, and global macro uncertainty driven by the US tariff environment. These risks could push the stock toward the bear case of Rs 340.
Recent Article
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026
Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026
